Tech boss quits after viral 'kiss cam' video at Coldplay concert
Andy Byron, the boss of New York-based firm Astronomer, was seen with his arms around Kristin Cabot, the company's chief people officer, on the 'kiss cam' screen at Gillette Stadium in Foxborough, Massachusetts,
When they saw themselves on the big screen, the pair quickly separated and attempted to hide their faces.
"Whoa, look at these two,' Coldplay singer Chris Martin said. 'Either they're having an affair or they're just very shy."
Mr Byron has now quit the data infrastructure company, according to a LinkedIn post from the company on Saturday.
Astronomer's board of directors accepted Byron's resignation, according to the LinkedIn post, and will begin searching for its next CEO.
The company added: 'As stated previously, Astronomer is committed to the values and culture that have guided us since our founding.
"Our leaders are expected to set the standard in both conduct and accountability, and recently, that standard was not met."
The data operations company, which was founded in 2018, acknowledged that 'awareness of our company may have changed overnight,' but its mission would continue to be focused on addressing data and artificial intelligence problems.
The company on Friday said Astronomer's co-founder and chief product officer Pete DeJoy would serve as interim CEO.
Mr Byron's LinkedIn account is no longer public and he was removed from the company's leadership page following the announcement, which now lists co-founder DeJoy as CEO.
Mr Byron is still listed on the company's website as a member of the board of directors.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
23 minutes ago
- Reuters
Baking giant Bimbo vows to cut artificial colorings by end-2026
MEXICO CITY, July 24 (Reuters) - Grupo Bimbo ( opens new tab, one of the world's largest breadmakers, said on Thursday it would cut artificial colorings from all of its products by the end of next year, as consumers turn more health-conscious when shopping for staple foods. Shorter term, executives at the Mexico City-based company said Bimbo's entire bread bun and breakfast range would by the end of this year have a positive nutrition - or a so-called health star rating - of at least 3.5 stars, as it looks to simplify recipes and boost nutrition by 2030. Scientists have linked synthetic dyes such as Red 40 and Yellow 5 to behavioral challenges, allergies and respiratory issues in children and other vulnerable consumers, and some major regulators have ordered usage caps and label warnings. In parts of the U.S., some activists have pushed for bans on synthetic dyes particularly in food destined for school meals. Bimbo estimates it is the largest single supplier of baked goods worldwide, with a close to 4% global market share of a $641 billion industry. It sells thousands of well-known staple products worldwide such as sliced bread and packaged snacks. Last year, these brought in $22 billion in sales. Executives said they did not expect a major cost impact from cutting artificial colorings. "By the end of 2026, we will have removed artificial colors from all our portfolio and by 2030 we're going to ensure that 100% of our baked goods and snacks will be made with simple, natural recipes," Bimbo Chief Financial Officer Diego Gaxiola told analysts in a call. "We're seeing that for younger consumers functional benefits are clearly important. It's not a fad, it's a trend."
Reuters
2 hours ago
- Reuters
Edwards Lifesciences raises annual sales forecast on strong demand for heart devices
July 24 (Reuters) - Edwards Lifesciences (EW.N), opens new tab raised its 2025 sales forecast on Thursday, citing strong demand for its artificial heart valves and other medical devices, after posting better-than-expected results for the second quarter. Shares of the California-based company rose about 8% in extended trading. Investor confidence in medical device makers has climbed in recent quarters, underpinned by robust demand for surgical procedures, particularly among older adults. Edwards now expects full-year sales in the range of $5.9 billion to $6.1 billion, having raised the lower end of its previous forecast from $5.7 billion while maintaining the upper end. Earlier on Thursday, larger rival Boston Scientific (BSX.N), opens new tab also raised its annual profit forecast, buoyed by strong demand for its heart devices. Sales of Edwards' flagship transcatheter aortic valve replacement (TAVR) devices, used in minimally invasive heart surgeries, jumped 8.9% to $1.13 billion in the quarter ended June 30, topping analysts' average estimate of $1.09 billion, according to data compiled by LSEG. On an adjusted basis, Edwards earned 67 cents per share in the second quarter, beating Wall Street's estimate of 62 cents per share. It reported revenue of $1.53 billion, surpassing market expectation of $1.49 billion. The company said it now expects its 2025 adjusted earnings to come in at the high end of its earlier forecast range of $2.40 to $2.50 per share. Edwards said its forecast factors in current tariffs and warned that any changes or new tariffs could significantly impact future results.
The Independent
3 hours ago
- The Independent
MTG again lashes out at Trump this time over his AI plan: ‘An absolute threat to federalism'
Republican Rep. Marjorie Taylor Greene, a staunch ally of the MAGA movement, broke from President Donald Trump on Thursday to oppose his executive order on artificial intelligence, raising concerns about its impact on the environment and states' rights. Hoping to accelerate the United States's development of AI, Trump signed a series of executive orders on Wednesday, making it easier to build data centers on federal lands and incentivizing states to impose fewer regulations by threatening to withhold federal funding to AI projects. But Greene raised a red flag, saying she was concerned with the impact of massive data centers on the people and environment around, while providing little to no regulations. 'My deep concerns are that the EO demands rapid AI expansion with little to no guardrails and breaks. It also contains the threat of withholding federal funds from states who regulate AI, which is an absolute threat to federalism and why I strongly opposed the AI state moratorium originally in the BBB,' Greene wrote on X. Trump has pushed for more AI development in the U.S., hoping for companies such as Meta, Google, OpenAI, and Microsoft to develop and expand their AI technology beyond what the Chinese-based company DeepSeek has already done. But the Georgia congresswoman said the 'rushed AI expansion' should include a plan to address human and environmental impact – with particular concerns around using nearby water supplies that cross state lines. 'Competing with China does not mean become like China by threatening state rights, replacing human jobs on mass scale creating mass poverty, and creating potentially devastating effects on our environment and critical water supply,' Greene wrote. 'This needs a careful and wise approach. The AI EO takes the opposite.' Greene's statement is the latest in a string of opposing stances that she has taken against Trump, whom she has typically expressed unwavering loyalty to. Recently, Greene has also criticized the administration for not releasing the Epstein Files, a recent Trump-backed crypto bill, and the president's decision to intervene in the Iran–Israel conflict by bombing Iranian nuclear facilities. Her additional opposition also comes at a moment of contention between the president and his MAGA base. Trump's dismissal of the Epstein Files, of which conspiracy theories have floated in the MAGA world for years, appears to have caused a fracture in his base's trust. It's unclear how many may feel about the AI bill, but Greene's opposition provides some insight. 'I represent the base and when I'm frustrated and upset over the direction of things, you better be clear, the base is not happy,' Greene said on X back in May.
